Latest | F'cast | |
---|---|---|
Div Yield | 2.9% | 0.0% |
Div Cover | 3.1 | 2.8 |
Op Mrgn | 12.8% | 22.1% |
ROCE | 15.8% |
Latest | F'cast | |
---|---|---|
P/E | 11.1 | 12.3 |
PEG | 0.5 | n/a |
Pr/Revenue | 1.9 | 1.4 |
Pr/Book | 2.5 |
Latest | F'cast | |
---|---|---|
Revenue | 14.2% | -17.8% |
PBT | 20.6% | 86.3% |
EPS | 23.2% | -9.3% |
DPS | 28.6% | -38.5% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 2,207.00 | 491.00 | 150.40¢ | 16.8 | 1.9 | +9% | 44.00¢ | 1.7% |
31-Dec-20 | 2,341.00 | 558.00 | 172.90¢ | 18.5 | 1.2 | +15% | 50.00¢ | 1.6% |
31-Dec-21 | 2,553.00 | 544.00 | 194.80¢ | 14.5 | 1.1 | +13% | 54.00¢ | 1.9% |
31-Dec-22 | 2,517.00 | 233.00 | 181.00¢ | 10.9 | n/a | -7% | 56.00¢ | 2.8% |
31-Dec-23 | 2,875.00 | 281.00 | 223.00¢ | 10.2 | 0.4 | +23% | 72.00¢ | 3.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 2,999.28 | 664.24 | 158.98p | 12.3 | n/a | -9% | 56.21p | 0.0% |
31-Dec-25 | 3,093.00 | 705.36 | 175.70p | 11.1 | 1.1 | +10% | 59.69p | 0.0% |
31-Dec-26 | 3,239.91 | 747.92 | 192.20p | 10.2 | 1.1 | +9% | 64.83p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Director/PDMR Shareholding | 05-Jun-2024 | 14:53 | RNS |
Director/PDMR Shareholding | 09-May-2024 | 09:49 | RNS |
Result of AGM | 25-Apr-2024 | 14:28 | RNS |
Hikma boosts injectables business with $300m deal | 29-May-2014 | Telegraph |
MARKET REPORT: Shares jump as Hikma Pharmaceutic... | 08-May-2014 | Daily Mail |
Hikma prepares return to Libya | 26-Aug-2011 | The Independent |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1,958.00p |
Change Today | -36.00p |
% Change | -1.81 % |
52 Week High | 2,205.00 |
52 Week Low | 1,722.00 |
Volume | 199,146 |
Shares Issued | 221.89m |
Market Cap | £4,344.51m |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 1 |
Strong Sell | 0 |
Total | 11 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 21-Mar-24 | 10-Aug-23 |
Paid | 03-May-24 | 15-Sep-23 |
Amount | 47.00¢ | 25.00¢ |
Time | Volume / Share Price |
16:35 | 1,459 @ 1,958.00p |
16:35 | 268 @ 1,958.00p |
16:35 | 129,648 @ 1,958.00p |
16:35 | 565 @ 1,958.00p |
16:35 | 494 @ 1,958.00p |
You are here: research